{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T09:33:49Z","timestamp":1773308029270,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.jcv.2009.07.005","type":"journal-article","created":{"date-parts":[[2009,8,4]],"date-time":"2009-08-04T09:25:42Z","timestamp":1249377942000},"page":"117-123","source":"Crossref","is-referenced-by-count":48,"title":["Low pretreatment serum HBsAg level and viral mutations as predictors of response to PEG-interferon alpha-2b therapy in chronic hepatitis B"],"prefix":"10.1016","volume":"46","author":[{"given":"Pisit","family":"Tangkijvanich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piyawat","family":"Komolmit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varocha","family":"Mahachai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pattaratida","family":"Sa-nguanmoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apiradee","family":"Theamboonlers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Poovorawan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jcv.2009.07.005_bib1","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra031087","article-title":"Hepatitis B virus infection\u2014natural history and clinical consequences","volume":"350","author":"Ganem","year":"2004","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jcv.2009.07.005_bib2","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/hep.21627","article-title":"Management of hepatitis B: summary of a clinical research workshop","volume":"45","author":"Hoofnagle","year":"2007","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jcv.2009.07.005_bib3","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.cld.2007.08.010","article-title":"Interferon therapy for chronic hepatitis B","volume":"11","author":"Asselah","year":"2007","journal-title":"Clin Liver Dis"},{"issue":"2","key":"10.1016\/j.jcv.2009.07.005_bib4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11373-007-9225-8","article-title":"Hepatitis B viral factors and clinical outcomes of chronic hepatitis B","volume":"15","author":"Lin","year":"2008","journal-title":"J Biomed Sci"},{"issue":"2","key":"10.1016\/j.jcv.2009.07.005_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cld.2004.02.006","article-title":"Clinical significance of hepatitis B virus genotypes, variants, and mutants","volume":"8","author":"Wai","year":"2004","journal-title":"Clin Liver Dis"},{"issue":"5","key":"10.1016\/j.jcv.2009.07.005_bib6","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jhep.2006.06.018","article-title":"Specific mutations in enhancer II\/core promoter of hepatitis B virus subgenotypes C1\/C2 increase the risk of hepatocellular carcinoma","volume":"45","author":"Tanaka","year":"2006","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jcv.2009.07.005_bib7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/gut.2007.119859","article-title":"Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B\/C, specific mutations of enhancer II\/core promoter\/precore regions and HBV DNA levels","volume":"57","author":"Yuen","year":"2008","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.jcv.2009.07.005_bib8","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1053\/j.gastro.2007.09.002","article-title":"Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients","volume":"133","author":"Chen","year":"2007","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jcv.2009.07.005_bib9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2893.2006.00784.x","article-title":"Clinical significance of pre-S mutations in patients with genotype C hepatitis B virus infection","volume":"14","author":"Choi","year":"2007","journal-title":"J Viral Hepat"},{"issue":"5","key":"10.1016\/j.jcv.2009.07.005_bib10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/hep.1840010511","article-title":"Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis","volume":"1","author":"Knodell","year":"1981","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jcv.2009.07.005_bib11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1053\/j.gastro.2007.11.036","article-title":"Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach","volume":"134","author":"Pawlotsky","year":"2008","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jcv.2009.07.005_bib12","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1872-034X.2007.00254.x","article-title":"Molecular epidemiological study of hepatitis B virus in Thailand based on the analysis of pre-S and S genes","volume":"38","author":"Suwannakarn","year":"2008","journal-title":"Hepatol Res"},{"issue":"2","key":"10.1016\/j.jcv.2009.07.005_bib13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jviromet.2003.10.002","article-title":"Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay","volume":"115","author":"Deguchi","year":"2004","journal-title":"J Virol Methods"},{"issue":"3","key":"10.1016\/j.jcv.2009.07.005_bib14","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/hep.510310323","article-title":"Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B","volume":"31","author":"Erhardt","year":"2000","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.jcv.2009.07.005_bib15","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/jmv.20935","article-title":"Genetic characteristics of hepatitis B virus genotypes as a factor for interferon-induced HBeAg clearance","volume":"79","author":"Hou","year":"2007","journal-title":"J Med Virol"},{"issue":"10","key":"10.1016\/j.jcv.2009.07.005_bib16","first-page":"2150","article-title":"Core promoter mutations of hepatitis B virus for the response to interferon in e antigen-positive chronic hepatitis B","volume":"91","author":"Kanai","year":"1996","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.jcv.2009.07.005_bib17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1365-2893.2002.00347.x","article-title":"Sequential analysis of hepatitis B virus core promoter and precore regions in cancer survivor patients with chronic hepatitis B before, during and after interferon treatment","volume":"9","author":"Zampino","year":"2002","journal-title":"J Viral Hepat"},{"issue":"5","key":"10.1016\/j.jcv.2009.07.005_bib18","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1053\/jhep.2003.50453","article-title":"Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection","volume":"38","author":"Milich","year":"2003","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1016\/j.jcv.2009.07.005_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2004-828672","article-title":"Molecular virology of hepatitis B virus","volume":"24","author":"Locarnini","year":"2004","journal-title":"Semin Liver Dis"},{"issue":"1","key":"10.1016\/j.jcv.2009.07.005_bib20","first-page":"19","article-title":"Predictive value of precore hepatitis B virus mutations in spontaneous and interferon-induced hepatitis B e antigen clearance","volume":"21","author":"Lok","year":"1995","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jcv.2009.07.005_bib21","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1046\/j.1440-1746.2001.02451.x","article-title":"Effect of multiple mutations in the core promoter and pre-core\/core region of hepatitis B virus genome on the response to interferon in e antigen-positive chronic hepatitis B","volume":"16","author":"Zhang","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.jcv.2009.07.005_bib22","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1053\/j.gastro.2006.01.011","article-title":"High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases","volume":"130","author":"Chen","year":"2006","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jcv.2009.07.005_bib23","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.virusres.2007.02.021","article-title":"Hepatitis B virus genetic variability and evolution","volume":"127","author":"Kay","year":"2007","journal-title":"Virus Res"},{"issue":"2","key":"10.1016\/j.jcv.2009.07.005_bib24","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1053\/jhep.2002.30698","article-title":"Complex HBV populations with mutations in core promoter, C gene, and pre-S region are associated with development of cirrhosis in long-term renal transplant recipients","volume":"35","author":"Preikschat","year":"2002","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jcv.2009.07.005_bib25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/135965350701200107","article-title":"Prediction of treatment-related HBsAg loss in HBeAG-negative chronic hepatitis B: a clue from serum HBsAg levels","volume":"12","author":"Manesis","year":"2007","journal-title":"Antivir. Ther."},{"issue":"12","key":"10.1016\/j.jcv.2009.07.005_bib26","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.cgh.2007.09.005","article-title":"Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response","volume":"5","author":"Chan","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jcv.2009.07.005_bib27","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/hep.21282","article-title":"Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B","volume":"44","author":"Wursthorn","year":"2006","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.jcv.2009.07.005_bib28","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1053\/j.gastro.2005.03.009","article-title":"Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy","volume":"128","author":"Sung","year":"2005","journal-title":"Gastroenterology"},{"issue":"9454","key":"10.1016\/j.jcv.2009.07.005_bib29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(05)17701-0","article-title":"Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial","volume":"365","author":"Janssen","year":"2005","journal-title":"Lancet"},{"issue":"26","key":"10.1016\/j.jcv.2009.07.005_bib30","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1056\/NEJMoa043470","article-title":"Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B","volume":"352","author":"Lau","year":"2005","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jcv.2009.07.005_bib31","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1053\/gast.2003.50140","article-title":"Epidemiologic and virologic characteristics of hepatitis B virus genotype B having the recombination with genotype C","volume":"124","author":"Sugauchi","year":"2003","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.jcv.2009.07.005_bib32","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2893.2005.00713.x","article-title":"Mutations affecting the replication capacity of the hepatitis B virus","volume":"13","author":"Sheldon","year":"2006","journal-title":"J Viral Hepat"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653209003278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653209003278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T06:42:58Z","timestamp":1685083378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653209003278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S1386653209003278"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2009.07.005","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}